Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
33,166,548
-
Total 13F shares
-
2,306,452
-
Share change
-
+3,055
-
Total reported value
-
$3,275,197
-
Price per share
-
$1.42
-
Number of holders
-
22
-
Value change
-
+$4,340
-
Number of buys
-
3
-
Number of sells
-
6
Institutional Holders of Envoy Medical, Inc. - Class A Common Stock (COCH) as of Q2 2025
As of 30 Jun 2025,
Envoy Medical, Inc. - Class A Common Stock (COCH) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,306,452 shares.
The largest 10 holders included
Atlas Merchant Capital LLC, VANGUARD GROUP INC, Weiss Asset Management LP, Focus Partners Wealth, Arcus Capital Partners, LLC, DSG Capital Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, CIBC Private Wealth Group LLC, MORGAN STANLEY, and HighPoint Advisor Group LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.